In an effort to prevent conflicting regulatory standards from fracturing the transatlantic tech marketplace, European and American negotiators have signed a mutual recognition pact covering high-risk artificial intelligence applications.
Under the terms, an AI model certified for diagnostic imaging or flight navigation in the European Union will automatically receive accelerated authorization from the US Food and Drug Administration or Federal Aviation Administration.
Both sides also agreed to establish a shared synthetic dataset repository to test foundational models against systemic hallucinations.
